Transplantation-related features of patients classified according to WHO criteria
| . | Diagnosis, N = 365 . | ||
|---|---|---|---|
| MDS, n = 238 . | AML-MDS, n = 127 . | ||
| Time from diagnosis to allo-SCT, mo (range) | 9.5 (1-189.3) | 8.3 (1-15.2) | |
| Type of donor (%) | |||
| Sibling | 9.166 (70) | 83 (65) | |
| MUD | 72 (30) | 44 (35) | |
| Source of hematopoietic stem cells (%) | |||
| Peripheral blood/cord blood | 139 (58) | 61 (48) | |
| Bone marrow | 99 (42) | 66 (52) | |
| Remission-induction chemotherapy (%) | 79 (33) | 91 (72) | |
| Complete remission (%) | 46 (58) | 49 (54) | |
| Standard conditioning regimen (%) | 156 (66) | 89 (70) | |
| RIC (%) | 82 (34) | 38 (30) | |
| . | Diagnosis, N = 365 . | ||
|---|---|---|---|
| MDS, n = 238 . | AML-MDS, n = 127 . | ||
| Time from diagnosis to allo-SCT, mo (range) | 9.5 (1-189.3) | 8.3 (1-15.2) | |
| Type of donor (%) | |||
| Sibling | 9.166 (70) | 83 (65) | |
| MUD | 72 (30) | 44 (35) | |
| Source of hematopoietic stem cells (%) | |||
| Peripheral blood/cord blood | 139 (58) | 61 (48) | |
| Bone marrow | 99 (42) | 66 (52) | |
| Remission-induction chemotherapy (%) | 79 (33) | 91 (72) | |
| Complete remission (%) | 46 (58) | 49 (54) | |
| Standard conditioning regimen (%) | 156 (66) | 89 (70) | |
| RIC (%) | 82 (34) | 38 (30) | |
MUD indicates matched unrelated donor; and RIC, reduced-intensity conditioning.